Zomedica Pharmaceuticals Corp. Announces First Quarter 2017 Financial Results

May 11, 2017

ANN ARBOR, Mich., May 11, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, today reported condensed unaudited interim consolidated financial results for the three months ended March 31, 2017. Amounts, unless specified otherwise, are expressed in U.S. dollars and presented under International Financial Reporting… [ READ MORE ]

Zomedica Announces Adoption of Advance Notice Bylaw

April 28, 2017

ANN ARBOR, Mich., April 28, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, announces the adoption of an advance notice bylaw (the “Advance Notice Bylaw”). The Advance Notice Bylaw includes, among other things, a provision that requires advance notice to be given to the… [ READ MORE ]

Zomedica Pharmaceuticals Corp. Files U.S. Registration Statement for Secondary Sales by Selling Shareholders

April 24, 2017

ANN ARBOR, Mich., April 24, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission (the “SEC”) on Form S-1 relating to the resale or other disposition by selling shareholders of up to… [ READ MORE ]

Zomedica Raises C$4.35 Million in Second Tranche Closing of Equity Financing for Aggregate Proceeds of C$5.54 Million

April 10, 2017

ANN ARBOR, Mich., April 10, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V: ZOM), a veterinary pharmaceutical company and health care solutions company, today announced the closing of the second and final tranche of its previously announced non-brokered private placement offering of common shares (each a “Common Share”) at a price of C$1.50 per Common… [ READ MORE ]

Zomedica Announces Ongoing Equity Financing

March 7, 2017

ANN ARBOR, Mich., March 07, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that its previously announced non-brokered private placement offering of up to 6,657,520 Common Shares at a price of C$1.50 per Common Share (each a “Common Share”) is ongoing. The first tranche of… [ READ MORE ]

Zomedica Pharmaceuticals Corp. Announces 2016 Year End Results

February 28, 2017

ANN ARBOR, Mich., Feb. 28, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, today reported consolidated financial results for the year ended December 31, 2016. Amounts, unless specified otherwise, are expressed in U.S. dollars and are presented under International Financial Reporting Standards as… [ READ MORE ]

Zomedica Announces Stock Option Grant and Pending Share Issuances

February 24, 2017

ANN ARBOR, Mich., Feb. 24, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V: ZOM) (“Zomedica” or the “Company”), a veterinary pharmaceutical and health care solutions company, today announced the grant of an aggregate of 535,000 options to acquire common shares of the Company to an officer and to an employee of the Company, each such… [ READ MORE ]

Zomedica Appoints Robert DiMarzo as Executive Vice President of Global Strategy

February 23, 2017

ANN ARBOR, Mich., Feb. 23, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V: ZOM), a veterinary pharmaceutical and health care solutions company, today announced that Robert W. DiMarzo has joined the company as Executive Vice President of Global Strategy. In this new company position, DiMarzo is responsible for expanding Zomedica’s business outside North America via… [ READ MORE ]